Use your melon. There is no "good news" waiting in the wings. Most concerning of all, Ropren is in serious doubt, now. When people don't keep you informed, there is always a reason.
PV1 Provaris tells ASX non-binding MOUs are still material to share prices in somewhat fiery compliance response